Media

Media

Zuvius Launches Zuvitop in 100mg Inj and 50mg caps

Admin / May 16, 2015 / Zuvitop

Zuvius Launches Zuvitop in 100mg Inj and 50mg caps, used in the treatment of Cancer.

ZUVITOP-100mg (ETOPOSIDE INJECTION IP)

COMPOISTION

Each ml contains:

Etoposide  IP………………. 20mg

Citric Acid IP ………………..2mg

Polysorbate 80 IP………… 80mg

Polyethylene glycol 300 IP… 650mg

Benzoyl alcohol IP …………..30 mg

Ethyl alcohol IP……………….. 30.5%v/v

Indications :

  • Etoposide Injection is indicated in the management of the following neoplasms.
  • Small cell lung cancer malignant lymphomas
  • Acute leukemia’s… Testicular tumors.
  • Bladder Cancer. Trophoblastic diseases
  • Etoposide Injection are indicated in the management of the following neoplasms.
  • Small cell lung cancer. Malignant lymphomas.

 

Packing :

Zuvitop-100mg injection vial of 5ml individually packed.

ZUVITOP-5mg (ETOPOSIDE CAPSULE IP)

COMPOISTION

Each Hard Gelatin Capsule contains:

Etoposide  IP ………………………..50mg

Excipients………………………………q.s

Approved colors used in capsule shell

Indications :

Zuvitop 50 capsules are indicated in the management of the following neoplasms:

  • Small cell lung cancer
  • Malignant lymphomas

 

Packing :

Zuvitop-50mg container of 8 capsules

500 mg/5mL Single-Use Vial

1000 mg/10mL Single-Use Vial

TOP
Login
Forgot Password ?

Not a member as yet? Register Now

In case you are using a public/shared computer we recommend that
you logout to prevent any un-authorized access to your account

forgot password

Reset Your Password

Enter email address to receive an email with the link to reset your password.

New User

hello , who are you?

I am a? *

Create Login Details

your contact details

I have read and understood and agree to Terms and Conditions the governing the use of zuviuslifescience.in.